Human Insulin

The Dongbao Pharmaceutical Co., Ltd., listed on the Shanghai Stock Exchange, is one of the most important Chinese insulin producers and the only producer of human insulin in China. The recombinant human insulin-production process was patented in 1999. Supplementary to the 10 ml "Gansulin" ampoules which were established years ago, the Dongbao Group will release insulin in 3 ml ampoules on the Chinese market soon.

The insulin produced by the Dongbao Group is of highest quality and meets the US-American FDA-standards in full scale. In addition to that it is much lower priced than our main competitors world-wide. We would very much like to co-operate with European producers for insulin preparation. We offer the European market "High Quality & Low Cost" human insulin raw material. This would drastically minimise the costs for the production of insulin preparation and therefore increase your market share correspondingly.